Jicong Cao

About Jicong Cao

Raina is at the forefront of generative AI for mRNA therapeutic design. Powered by its proprietary GEMORNA platform, we are breaking new ground in mRNA engineering, generating sequences with markedly enhanced translational efficiency, stability, and potency — results featured in Science.

Experience

1. Co-founder & CEO

   Raina Biosciences

   May 2023 — Present · Cambridge, MA, US

   Raina is developing the leading generative-AI-for-RNA platform to generate superior mRNAs with unprecedented translational capacity and stability. We integrate advanced AI and synthetic biology technologies to design the best therapeutic mRNA sequences with massive throughput and speed. Our mission is to accelerate drug discovery timelines and produce best-in-class RNA therapeutics for novel applications.

Education

• Rensselaer Polytechnic Institute

  Doctor of Philosophy (Ph.D.), Chemical and Biological Engineering

  2009 — 2014

• Tianjin University

  Bachelor of Science (B.S.), Biological Engineering

  2005 — 2009

Skills

• Size Exclusion Chromatography (Sec)
• Uv/Vis Spectroscopy
• Rna
• Confocal Microscopy
• Next-Generation Sequencing (Ngs)
• Protein Purification
• Cell
• Uv/Vis
• Libary Screening
• Optogenetics
• Cell Biology
• Site-Directed Mutagenesis
• Synthetic Biology
• Gel Electrophoresis
• Molecular Cloning
• Protein Expression
• Laboratory
• Gene Expression
• Mammalian Cell Culture
• Fluorescence Microscopy
• Sds-Page
• Cell Culture
• Western Blotting
• Protein Engineering
• Cell Line Engineering
• Flow Cytometry
• Antibody Expression